[go: up one dir, main page]

CZ20031333A3 - m-Amino-fenylimino-imidazolidinové deriváty a jejich použití pro výrobu léčiv - Google Patents

m-Amino-fenylimino-imidazolidinové deriváty a jejich použití pro výrobu léčiv Download PDF

Info

Publication number
CZ20031333A3
CZ20031333A3 CZ20031333A CZ20031333A CZ20031333A3 CZ 20031333 A3 CZ20031333 A3 CZ 20031333A3 CZ 20031333 A CZ20031333 A CZ 20031333A CZ 20031333 A CZ20031333 A CZ 20031333A CZ 20031333 A3 CZ20031333 A3 CZ 20031333A3
Authority
CZ
Czechia
Prior art keywords
dimethylamino
phen
iminoimidazolidine
methyl
chloro
Prior art date
Application number
CZ20031333A
Other languages
Czech (cs)
English (en)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of CZ20031333A3 publication Critical patent/CZ20031333A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ20031333A 2000-10-14 2001-10-11 m-Amino-fenylimino-imidazolidinové deriváty a jejich použití pro výrobu léčiv CZ20031333A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14

Publications (1)

Publication Number Publication Date
CZ20031333A3 true CZ20031333A3 (cs) 2003-08-13

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20031333A CZ20031333A3 (cs) 2000-10-14 2001-10-11 m-Amino-fenylimino-imidazolidinové deriváty a jejich použití pro výrobu léčiv

Country Status (23)

Country Link
EP (1) EP1328517A2 (xx)
JP (1) JP2004511547A (xx)
KR (1) KR20030046503A (xx)
CN (1) CN1471514A (xx)
AR (1) AR035923A1 (xx)
AU (1) AU2002215943A1 (xx)
BG (1) BG107711A (xx)
BR (1) BR0114603A (xx)
CA (1) CA2425563A1 (xx)
CZ (1) CZ20031333A3 (xx)
DE (1) DE10150312A1 (xx)
EA (1) EA200300460A1 (xx)
EC (1) ECSP034517A (xx)
EE (1) EE200300177A (xx)
HU (1) HUP0302245A3 (xx)
IL (1) IL155338A0 (xx)
MX (1) MXPA03003162A (xx)
NO (1) NO20031697L (xx)
PL (1) PL361359A1 (xx)
SK (1) SK4342003A3 (xx)
WO (1) WO2002032876A2 (xx)
YU (1) YU28203A (xx)
ZA (1) ZA200302345B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
NO20031697D0 (no) 2003-04-11
CN1471514A (zh) 2004-01-28
EE200300177A (et) 2003-08-15
YU28203A (sh) 2006-05-25
NO20031697L (no) 2003-05-26
MXPA03003162A (es) 2004-12-06
ZA200302345B (en) 2004-04-23
WO2002032876A2 (de) 2002-04-25
EP1328517A2 (de) 2003-07-23
BR0114603A (pt) 2003-10-14
KR20030046503A (ko) 2003-06-12
IL155338A0 (en) 2003-11-23
AU2002215943A1 (en) 2002-04-29
PL361359A1 (en) 2004-10-04
AR035923A1 (es) 2004-07-28
HUP0302245A3 (en) 2004-01-28
CA2425563A1 (en) 2002-04-25
WO2002032876A3 (de) 2002-07-18
ECSP034517A (es) 2003-04-25
DE10150312A1 (de) 2002-07-04
HUP0302245A2 (hu) 2003-10-28
JP2004511547A (ja) 2004-04-15
BG107711A (bg) 2004-02-27
EA200300460A1 (ru) 2004-02-26
SK4342003A3 (en) 2003-10-07

Similar Documents

Publication Publication Date Title
US4532331A (en) 1-Benzyl-2-aminomethyl imidazole derivatives
CN101006090A (zh) 4[[(7r)－8－环戊基－7－乙基－5,6,7,8－四氢－5－甲基－4－6－氧代－2－哌啶基]氨基]－3－甲氧基－n－(1－甲基－4－哌啶基)－苯甲酰胺的水合物及多晶型物，其制造方法及其作为药物的用途
CA2256687C (en) Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
JPH05148197A (ja) フエノキシフエニル誘導体
JPH05213894A (ja) Ｎ−置換ヘテロ環誘導体、製法および医薬組成物
NO324750B1 (no) Substituerte N-benzylindol-3-yl-glyokylinsyrederivater med anti-tumoreffekt, og farmasoytiske preparater som inneholder slike.
WO2003024937A1 (en) Benzimidazolylalkoxyaryl alkanoic acid derivatives and their use as antihyperglycemics
US4684650A (en) Antihypertensive fluorophenylindanyl imidazolidinoneethylpiperazines
US4835154A (en) 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
CA2304879A1 (en) New tetracycles, process for their production and pharmaceutical preparations containing these compounds
CZ20031333A3 (cs) m-Amino-fenylimino-imidazolidinové deriváty a jejich použití pro výrobu léčiv
EP0221778A2 (en) Dopamine-beta-hydroxylase inhibitors
US6602897B2 (en) m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
CS207750B2 (en) Method of making the n'-cyano-n'-alcyl-n-2-/5-methyl-1h-imidazol-4-yl/methyl thicethyl guanidines
CZ20032146A3 (cs) Imidazolidinové deriváty a jejich použití
US20020169193A1 (en) Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence
CA2696314C (en) Therapeutic compounds
JP2001506605A (ja) ２―アミノ―２―イミダゾリン、グアニジン、および２―アミノ―３，４，５，６―テトラヒドロピリミジン誘導体の製造法
JPH07101941A (ja) ２−［２−（置換アミノ）ベンジルチオ］−５，６， ７，８−テトラヒドロ−４（３ｈ）−キナゾリノン誘 導体
US4772723A (en) Dopamine β-hydroxylase inhibitors
US4863944A (en) Dopamine-β-hydroxylase inhibitors
US4873357A (en) Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors
CZ119594A3 (en) Derivatives of 2-aminopyrazine-5-carboxamide, process of their preparation and a pharmaceutical preparation in which they are comprised
HK1060568A (en) Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
WO2003011835A1 (en) Benzimidazolylalkyl-aryl(alkan) oic acid derivatives and their use as antihyperglycaemics